Tatva Chintan Pharma Chem Limited Price (TATVA.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

22,889,189

(3.267)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Tatva Chintan Pharma Chem Limited
news-img

Income Statement

Tatva Chintan Pharma Chem Limited

Currency: INR

YEAR 2017 2018 2019 2020 2021 2022 2023
Revenue
Revenue 1,337,000,000.00

+0%

2,024,490,000.00

+51%

2,576,850,000.00

+27%

2,968,570,000.00

+15%

4,312,930,000.00

+45%

4,236,120,000.00

-2%

3,904,950,000.00

-8%

Cost of Revenue
Cost of Revenue 1,015,410,000.00 1,163,010,000.00 1,384,400,000.00 1,554,660,000.00 2,076,780,000.00 2,261,010,000.00 3,204,270,000.00
Gross Profit
Gross Profit 321,590,000.00

+0%

861,480,000.00

+168%

1,192,450,000.00

+38%

1,413,910,000.00

+19%

2,236,150,000.00

+58%

1,975,110,000.00

-12%

700,680,000.00

-65%

Gross Profit Ratio (0.24%) (0.43%) (0.46%) (0.48%) (0.52%) (0.47%) (0.18%)
Operating Expenses
Research and Development 1,890,000.00 1,990,000.00 10,140,000.00 2,790,000.00 37,070,000.00 60,390,000.00 79,420,000.00
General and Administrative 0.00 39,530,000.00 22,740,000.00 22,930,000.00 43,840,000.00 50,670,000.00 58,900,000.00
Selling, General & Admin... 132,620,000.00 198,740,000.00 192,970,000.00 214,810,000.00 382,100,000.00 404,760,000.00 219,260,000.00
Selling & Marketing Exp... 0.00 159,210,000.00 170,230,000.00 191,880,000.00 338,260,000.00 287,660,000.00 225,130,000.00
Depreciation and Amortiz... 29,520,000.00 40,180,000.00 47,930,000.00 67,320,000.00 81,800,000.00 95,550,000.00 256,050,000.00
Other Expenses -2,040,000.00 390,000.00 453,130,000.00 4,500,000.00 1,330,000.00 57,440,000.00 0.00
Total Operating Expenses 136,550,000.00 541,050,000.00 656,240,000.00 807,890,000.00 1,228,220,000.00 1,464,850,000.00 642,470,000.00
Cost and Exponses 1,151,960,000.00 1,704,060,000.00 2,040,640,000.00 2,362,550,000.00 3,305,000,000.00 3,725,860,000.00 3,506,730,000.00
Operating Income
Operating Income 185,040,000.00

+0%

317,000,000.00

+71%

532,500,000.00

+68%

601,810,000.00

+13%

1,004,840,000.00

+67%

584,690,000.00

-42%

422,170,000.00

-28%

Operating Income Ratio (0.14%) (0.16%) (0.21%) (0.20%) (0.23%) (0.14%) (0.11%)
Other Income and Exp...
Interest Income 0.00 2,710,000.00 5,170,000.00 3,590,000.00 45,490,000.00 41,590,000.00 23,960,000.00
Interest Expenses 19,380,000.00 32,980,000.00 37,520,000.00 39,850,000.00 42,320,000.00 84,040,000.00 61,510,000.00
Total Other Income/Exp... 5,300,000.00 -46,500,000.00 -60,240,000.00 -546,350,000.00 -923,590,000.00 -131,560,000.00 13,510,000.00
EBITDA
EBITDA 245,960,000.00 353,390,000.00 566,190,000.00 717,710,000.00 1,169,630,000.00 626,960,000.00 756,710,000.00
EBITDA ratio (0.16%) (0.17%) (0.22%) (0.24%) (0.27%) (0.16%) (0.19%)
Income Before Tax
Income Before Tax 190,340,000.00 273,930,000.00 475,970,000.00 606,960,000.00 1,041,210,000.00 447,790,000.00 435,680,000.00
Income Before Tax Ratio (0.14%) (0.14%) (0.18%) (0.20%) (0.24%) (0.11%) (0.11%)
Income Tax Expense
Income Tax Expense 67,450,000.00 68,500,000.00 98,080,000.00 84,340,000.00 82,470,000.00 -7,080,000.00 132,139,999.00
Net Income
Net Income 122,890,000.00

+0%

205,430,000.00

+67%

377,890,000.00

+84%

522,620,000.00

+38%

958,740,000.00

+83%

454,870,000.00

-53%

303,540,000.00

-33%

Net Income Ratio (0.09%) (0.10%) (0.15%) (0.18%) (0.22%) (0.11%) (0.08%)
Earning Per Share
Basic EPS 6.12 10.23 18.81 26.02 44.59 20.52 13.26
Diluted EPS 6.12 10.23 18.81 26.02 44.59 20.52 13.26
Share Outstanding
Basic Share Outstanding 20,087,500.00 20,087,500.00 20,087,500.00 20,087,500.00 21,499,104.00 22,165,062.00 22,891,402.00
Diluted Share Outstanding 20,087,500.00 20,087,500.00 20,087,500.00 20,087,500.00 21,499,104.00 22,165,062.00 22,889,189.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation